Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Authors
Keywords
-
Journal
ALLERGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-11-17
DOI
10.1111/all.15585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study
- (2022) Diego Alvarado et al. ALLERGY
- Evidence for histamine release in chronic inducible urticaria – A systematic review
- (2022) Kanokvalai Kulthanan et al. Frontiers in Immunology
- Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
- (2021) Yudi Chen et al. World Allergy Organization Journal
- Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response
- (2021) Miao Yu et al. CLINICAL AND EXPERIMENTAL ALLERGY
- The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
- (2021) T. Zuberbier et al. ALLERGY
- The c-kit Receptor Tyrosine Kinase Marks Sweet or Umami Sensing T1R3 Positive Adult Taste Cells in Mice
- (2020) Ezen Choo et al. Chemosensory Perception
- Symptomatic Dermographism: A Systematic Review of Treatment Options
- (2020) Kanokvalai Kulthanan et al. Journal of Allergy and Clinical Immunology-In Practice
- Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results
- (2020) Marcus Maurer et al. World Allergy Organization Journal
- Cold urticaria – What we know and what we do not know
- (2020) Natalya Maltseva et al. ALLERGY
- Executive summary of the methods report for ‘The EAACI/GA2 LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update’
- (2018) C. Dressler et al. ALLERGY
- The role and relevance of mast cells in urticaria
- (2018) Martin K. Church et al. IMMUNOLOGICAL REVIEWS
- Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
- (2018) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mast Cells as Drivers of Disease and Therapeutic Targets
- (2018) Frank Siebenhaar et al. TRENDS IN IMMUNOLOGY
- How to Approach Chronic Inducible Urticaria
- (2018) Marcus Maurer et al. Journal of Allergy and Clinical Immunology-In Practice
- Identification of hair shaft progenitors that create a niche for hair pigmentation
- (2017) Chung-Ping Liao et al. GENES & DEVELOPMENT
- Omalizumab is effective in symptomatic dermographism—results of a randomized placebo-controlled trial
- (2017) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Responsiveness and minimal important difference of the urticaria control test
- (2017) Tatevik Ohanyan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial
- (2017) Martin Metz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Management of chronic inducible urticaria according to the guidelines: A prospective controlled study
- (2017) Emek Kocatürk et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision
- (2016) M. Magerl et al. ALLERGY
- Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT)
- (2016) Kanokvalai Kulthanan et al. Health and Quality of Life Outcomes
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
- (2014) Karsten Weller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The diagnosis and management of acute and chronic urticaria: 2014 update
- (2014) Jonathan A. Bernstein et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria
- (2014) M. Magerl et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism
- (2013) A. Mlynek et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now